https://orcid.org/0000-0002-6817-7289
References
- Diaz JH. Syndromic diagnosis and management of confirmed mushroom poisonings. Crit Care Med. 2005;33(2):427–436.
- Letschert K, Faulstich H, Keller D, et al. Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicol Sci. 2006;91(1):140–149.
- Magdalan J, Piotrowska A, Gomułkiewicz A, et al. Benzylpenicyllin and acetylcysteine protection from α-amanitin-induced apoptosis in human hepatocyte cultures. Exp Toxicol Pathol. 2011;63(4):311–315.
- Kroncke KD, Fricker G, Meier PJ, et al. alpha-Amanitin uptake into hepatocytes. Identification of hepatic membrane transport systems used by amatoxins. J Biol Chem. 1986;261(27):12562–12567.
- Enjalbert F, Rapior S, Nouguier-Soule J, et al. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol. 2002;40(6):715–757.
- Poucheret P, Fons F, Dore JC, et al. Amatoxin poisoning treatment decision-making: pharmaco-therapeutic clinical strategy assessment using multidimensional multivariate statistic analysis. Toxicon. 2010;55(7):1338–1345.
- Floersheim GL. Antagonistic effects to phalloidin, alpha-amanitin and extracts of Amanita phalloides. Agents Actions. 1971;2(3):142–149.
- Floersheim GL. Rifampicin and cysteamine protect against the mushroom toxin phalloidin. Experientia. 1974;30(11):1310–1312.
- Giannini L, Vannacci A, Missanelli A, et al. Amatoxin poisoning: a 15-year retrospective analysis and follow-up evaluation of 105 patients. Clin Toxicol (Phila). 2007;45(5):539–542.